0001104659-19-019036.txt : 20190401 0001104659-19-019036.hdr.sgml : 20190401 20190401180104 ACCESSION NUMBER: 0001104659-19-019036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190329 FILED AS OF DATE: 20190401 DATE AS OF CHANGE: 20190401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holles Natalie C. CENTRAL INDEX KEY: 0001580111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 19722129 MAIL ADDRESS: STREET 1: C/O HYPERION THERAPEUTICS, INC. STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2019-03-29 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001580111 Holles Natalie C. C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 18.10 2019-03-29 4 A 0 50000 0 A 2029-03-28 Common Stock 50000 50000 D This option shall vest in equal quarterly installments over the twelve quarters following the grant date. /s/ Joanne M. Protano, Attorney-in-Fact 2019-04-01